recognized for our innovation, quality, and customer convenience, labcorp delivers timely, accurate results for improved patient care. with scientific expertise in esoteric testing, genomics, and clinical and anatomic pathology, labcorp performs more than one million tests on approximately 400,000 samples each day. labcorp is a pioneer in applying advances in medicine and science to laboratory testing, with more than 35 years of experience in serving physicians and their patients. labcorp operates a sophisticated laboratory network, with corporate headquarters in burlington, nc, and more than 34,000 employees worldwide. our more than 220,000 clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies. laboratory corporation of america holdings is listed on the new york stock exchange (nyse) under ticker symbol lh.

Company profile
Ticker
LH
Exchange
Website
CEO
Adam Schechter
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
NATIONAL HEALTH LABORATORIES HOLDINGS INC
SEC CIK
Corporate docs
Subsidiaries
2248848 Ontario Inc. • 3065619 Nova Scotia Company • 3257959 Nova Scotia Company • 896988 Ontario Limited • Accupath Diagnostic Laboratories, Inc. • Beacon Laboratory Benefit Solutions, Inc. • BeaconLBS IPA, Inc. • CannAmm GP Inc. • CannAmm Limited Partnership • Center for Disease Detection, LLC ...
IRS number
133757370
LH stock data
Analyst ratings and price targets
Latest filings (excl ownership)
8-K
Labcorp to Present Strategy, Business and Financial Outlook at Investor Day
14 Sep 23
8-K
Departure of Directors or Certain Officers
11 Sep 23
8-K
Regulation FD Disclosure
9 Aug 23
10-Q
2023 Q1
Quarterly report
4 Aug 23
8-K
Regulation FD Disclosure
31 Jul 23
8-K
Labcorp Announces 2023 Second Quarter Results
27 Jul 23
8-K
Labcorp Declares Quarterly Dividend
13 Jul 23
8-K/A
Financial Statements and Exhibits
7 Jul 23
8-K
Labcorp Completes Spin-off of Fortrea
3 Jul 23
8-K
Regulation FD Disclosure
29 Jun 23
Transcripts
LH
Earnings call transcript
2023 Q2
27 Jul 23
LH
Earnings call transcript
2023 Q1
25 Apr 23
LH
Earnings call transcript
2022 Q4
16 Feb 23
LH
Earnings call transcript
2022 Q3
27 Oct 22
LH
Earnings call transcript
2022 Q2
28 Jul 22
LH
Earnings call transcript
2022 Q1
28 Apr 22
LH
Earnings call transcript
2021 Q4
10 Feb 22
LH
Earnings call transcript
2021 Q3
28 Oct 21
LH
Earnings call transcript
2021 Q2
29 Jul 21
LH
Earnings call transcript
2021 Q1
29 Apr 21
Latest ownership filings
4
KERRII B ANDERSON
10 Aug 23
144
Notice of proposed sale of securities
8 Aug 23
4
Peter J Wilkinson
3 Aug 23
SC 13D/A
ENZO BIOCHEM INC
24 Jul 23
4
der Vaart Sandra D van
5 Jul 23
4
Peter J Wilkinson
5 Jul 23
4
Amy B. Summy
5 Jul 23
4
Mark S Schroeder
5 Jul 23
4
Adam H Schechter
5 Jul 23
4
GLENN A EISENBERG
5 Jul 23
Financial summary
Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q2 2023
88.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 887 |
Opened positions | 88 |
Closed positions | 108 |
Increased positions | 282 |
Reduced positions | 348 |
13F shares | Current |
---|---|
Total value | 18.10 tn |
Total shares | 77.93 mm |
Total puts | 242.10 k |
Total calls | 539.30 k |
Total put/call ratio | 0.4 |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 12.70 mm | $3.07 tn |
Vanguard | 10.33 mm | $2.49 tn |
STT State Street | 3.93 mm | $948.56 bn |
Wellington Management | 2.06 mm | $497.72 bn |
Geode Capital Management | 1.88 mm | $451.58 bn |
Lazard Asset Management | 1.73 mm | $417.17 mm |
BAC Bank Of America | 1.47 mm | $354.38 bn |
Dimensional Fund Advisors | 1.46 mm | $352.38 bn |
JPM JPMorgan Chase & Co. | 1.44 mm | $346.71 bn |
Ubs Global Asset Management Americas | 1.20 mm | $275.23 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Aug 23 | Anderson Kerrii B | Common Stock | Sell | Dispose S | No | No | 211.5665 | 5,000 | 1.06 mm | 15,275 |
1 Aug 23 | Peter J Wilkinson | Common Stock | Payment of exercise | Dispose F | No | No | 213.61 | 17 | 3.63 k | 3,471.219 |
1 Aug 23 | Peter J Wilkinson | Common Stock | Option exercise | Acquire M | No | No | 0 | 56 | 0.00 | 3,488.219 |
1 Aug 23 | Peter J Wilkinson | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 56 | 0.00 | 3,858 |
29 Jun 23 | van der Vaart Sandra D | Common Stock | Sell | Dispose S | No | Yes | 240 | 212 | 50.88 k | 7,604.698 |
20 Jun 23 | Laboratory Corp. Of America | Common Stock | Other | Dispose J | No | No | 0 | 100 | 0.00 | 0 |
News
B of A Securities Maintains Buy on Laboratory Corp, Lowers Price Target to $230
21 Sep 23
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
21 Sep 23
Baird Maintains Outperform on Laboratory Corp, Lowers Price Target to $237
18 Sep 23
Truist Securities Reiterates Buy on Laboratory Corp, Maintains $270 Price Target
15 Sep 23
Mizuho Reiterates Buy on Laboratory Corp, Maintains $257 Price Target
15 Sep 23
Press releases
Labcorp to Present Strategy, Business and Financial Outlook at Investor Day
14 Sep 23
Singular Genomics Appoints Genomics Veteran Marcia Eisenberg, Ph.D., to Board of Directors
8 Aug 23
Labcorp Forges Strategic Partnership with Tufts Medicine, Will Acquire Outreach Laboratory Business
3 Aug 23
Labcorp to Host Investor Day on September 14, 2023
31 Jul 23
Labcorp Announces 2023 Second Quarter Results
27 Jul 23